Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood

Lucy Riglin, Sharifah Shameem Agha, Olga Eyre, Rhys Bevan Jones, Robyn E Wootton, Ajay K Thapar, Stephan Collishaw, Evie Stergiakouli, Kate Langley, Anita Thapar
doi: https://doi.org/10.1101/2021.02.02.20248239
Lucy Riglin
aDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharifah Shameem Agha
aDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, UK
bCwm Taf Morgannwg University Health Board, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Eyre
aDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rhys Bevan Jones
aDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, UK
bCwm Taf Morgannwg University Health Board, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robyn E Wootton
cMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
dPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajay K Thapar
aDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Collishaw
aDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evie Stergiakouli
cMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
eNic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate Langley
aDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, UK
fSchool of Psychology, Cardiff University, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita Thapar
aDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Wales, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Thapar{at}Cardiff.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) symptoms typically onset early in development and persist into adulthood for many. Robust investigation of symptom continuity and discontinuity requires repeated assessments using the same measure, but research is lacking into whether measures used to assess ADHD symptoms in childhood are also valid in adulthood. The Strengths and Difficulties Questionnaire (SDQ) has been widely used to measure ADHD symptoms in children, but little is known about its utility to measure ADHD in adulthood. We used Receiver Operating Characteristic (ROC) curve analyses to examine the validity of the SDQ hyperactivity/ADHD subscale to distinguish between cases and non-cases of DSM-5 ADHD classified using the Barkley Adult ADHD Rating Scale-IV (BAARS-IV) at age 25 years in a UK population cohort (N=4121). Analyses suggested that the SDQ ADHD subscale had high accuracy in distinguishing ADHD cases from non-cases in young adulthood (area under the curve=0.90, 95% CI=0.87-0.93) and indicated a lower cut-point for identifying those who may have an ADHD diagnosis in this age group compared to that currently recommended for younger ages.Our findings suggest that the SDQ is suitable for ADHD research across different developmental periods, which will aid the robust investigation of ADHD from childhood to young adulthood.

Highlights

  • The SDQ is widely used to measure ADHD symptoms in children

  • We investigated the validity of the SDQ to assess ADHD at age 25 years

  • The SDQ ADHD subscale had high accuracy in distinguishing DSM-5 ADHD cases from non-cases

  • A lower cut-point is needed to identify ADHD diagnosis in young adulthood compared to younger ages

  • The SDQ is appropriate for ADHD research across different development periods

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The measures used in the paper were specifically funded by the Wellcome Trust (204895/Z/16/Z). REW and ES work in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_00011/1 and MC_UU_00011/3). RBJ is supported by the Welsh Government through Health and Care Research Wales (National Institute for Health Research Fellowship, NIHR-PDF-2018). REW is supported by a postdoctoral fellowship from the South-Eastern Regional Health Authority (2020024). This study was supported by the Wellcome Trust (204895/Z/16/Z).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee (IRB00003312) and Local Research Ethics Committees which includes:

Bristol and Weston Health Authority: E1808 Children of the Nineties: Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC). (28th November 1989)

Southmead Health Authority: 49/89 Children of the Nineties – “ALSPAC”. (5th April 1990)

Frenchay Health Authority: 90/8 Children of the Nineties. (28th June 1990)

Further details of these can be found on our webpages at http://www.bristol.ac.uk/media-library/sites/alspac/documents/governance/Research%20Ethics%20Committee%20approval%20references.pdf

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool: http://www.bristol.ac.uk/alspac/researchers/our-data/.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted February 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood
Lucy Riglin, Sharifah Shameem Agha, Olga Eyre, Rhys Bevan Jones, Robyn E Wootton, Ajay K Thapar, Stephan Collishaw, Evie Stergiakouli, Kate Langley, Anita Thapar
medRxiv 2021.02.02.20248239; doi: https://doi.org/10.1101/2021.02.02.20248239
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood
Lucy Riglin, Sharifah Shameem Agha, Olga Eyre, Rhys Bevan Jones, Robyn E Wootton, Ajay K Thapar, Stephan Collishaw, Evie Stergiakouli, Kate Langley, Anita Thapar
medRxiv 2021.02.02.20248239; doi: https://doi.org/10.1101/2021.02.02.20248239

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)